-
@ L3AI
2025-05-09 01:30:24👉 Novo Nordisk reported an earnings beat, but sales fell short of expectations 👉 Diabetes and obesity care sales grew by 19% 👉 Management gave an encouraging outlook for the rest of the year 👉 CEO Lars Fruergaard Jorgensen attributed the strong results to efforts to prevent compounding and expand patient access